The Asia-Pacific proteomics market is expected to soar from $6.95 billion in 2024 to $25.78 billion by 2034, demonstrating a robust CAGR of 14.01%. This rapid expansion is fueled by advances in next-generation sequencing and mass spectrometry technologies enabling precise protein analysis, alongside a growing emphasis on personalized healthcare, biomarker discovery, and disease profiling. Public-private collaborations and government-backed R&D initiatives are accelerating proteomics innovation,Read More
Asia-Pacific Proteomics Market Research Report 2024-2034 | Increasing Automation for End-to-End Proteomics Workflow & Growing Research to Identify Disease Biomarkers
